{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:22Z","timestamp":1792730302315,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.expneurol.2026.116041","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:11:11Z","timestamp":1790291471000},"page":"116041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of multidimensional molecular mechanisms in Parkinson's disease and precise therapeutic strategies"],"prefix":"10.1016","volume":"407","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.116041_bb0005","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-212739","article-title":"Gene therapy for Parkinson\u2019s disease associated with GBA1 mutations","volume":"11","author":"Abeliovich","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20211288","article-title":"Modeling Parkinson\u2019s disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway","volume":"50","author":"Albanese","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.116041_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis -an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.expneurol.2026.116041_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfy219","article-title":"Inflammasomes: an emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson\u2019s disease","volume":"166","author":"Anderson","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104515","article-title":"miR-124 and Parkinson\u2019s disease: a biomarker with therapeutic potential","volume":"150","author":"Angelopoulou","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0030","article-title":"Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson\u2019s disease: molecular mechanisms connecting neuroinflammation to \u03b1-synuclein spreading pathology","volume":"9","author":"Angelopoulou","year":"2020","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.expneurol.2026.116041_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.116041_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2025.06.035","article-title":"GIT 27 modulates TLR4\/Src\/NOX2 signaling pathway: a potential therapeutic strategy to decrease neuroinflammation, oxidative stress and neuronal cell death in Parkinson\u2019s disease","volume":"238","author":"Ardizzone","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and Neuroinflammation in Parkinson\u2019s disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/jnc.13261","article-title":"Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson\u2019s disease","volume":"135","author":"Ay","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.116041_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1566524022666220203163631","article-title":"An insight into the molecular mechanism of mitochondrial toxicant-induced neuronal apoptosis in Parkinson\u2019s disease","volume":"23","author":"Brahadeeswaran","year":"2023","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105221","article-title":"Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson\u2019s disease via inhibiting p38MAPK\/NF-\u03baB signaling pathway","volume":"152","author":"Cai","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2026.116041_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040955","article-title":"Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products","volume":"12","author":"Chakrabarti","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.expneurol.2026.116041_bb0070","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1016\/j.cell.2023.10.004","article-title":"Circuit-specific gene therapy reverses core symptoms in a primate Parkinson's disease model","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.116041_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107895","article-title":"Artesunate alleviates Parkinson\u2019s disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis","volume":"219","author":"Cheng","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103256","article-title":"The autoimmune response induced by \u03b1-synuclein peptides drives neuronal cell death and glial cell activation","volume":"147","author":"Choe","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0085","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/mds.29518","article-title":"Post-mortem studies of neurturin gene therapy for Parkinson\u2019s disease: two subjects with 10years CERE120 delivery","volume":"38","author":"Chu","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.116041_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2026.116041_bb0095","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/mds.29577","article-title":"27-hydroxycholesterol drives the spread of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"38","author":"Dai","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.116041_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01127-z","article-title":"The hibernation-derived compound SUL-138 shifts the mitochondrial proteome towards fatty acid metabolism and prevents cognitive decline and amyloid plaque formation in an Alzheimer's disease mouse model","volume":"14","author":"de Veij Mestdagh","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.expneurol.2026.116041_bb0105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113383","article-title":"AmyP53, a therapeutic peptide candidate for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease: safety, stability, pharmacokinetics parameters and nose-to brain delivery","volume":"23","author":"Di Scala","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson\u2019s disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111629","article-title":"Convergence of Neuroinflammation, microbiota, and Parkinson\u2019s disease: therapeutic insights and prospects","volume":"25","author":"Dom\u00ednguez Rojo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JPD-240019","article-title":"The body, the brain, the environment, and Parkinson\u2019s disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1039\/D5SC06116D","article-title":"Ambroxol displaces \u03b1-synuclein from the membrane and inhibits the formation of early protein-lipid coaggregates","volume":"17","author":"Dreier","year":"2026","journal-title":"Chem. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0140","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","article-title":"Mitochondrial quality control in health and in Parkinson\u2019s disease","volume":"102","author":"Eldeeb","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0145","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114745","article-title":"LAG3 is not expressed in human and murine neurons and does not modulate \u03b1-synucleinopathies","volume":"13","author":"Emmenegger","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0150","series-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","article-title":"Apoptosis and its role in Parkinson\u2019s disease","author":"Erekat","year":"2018"},{"key":"10.1016\/j.expneurol.2026.116041_bb0155","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4103\/NRR.NRR-D-25-00076","article-title":"Targeting gangliosides to treat Alzheimer\u2019s and Parkinson\u2019s diseases: a disruptive approach with the first-in-class peptide AmyP53","volume":"21","author":"Fantini","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0160","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1038\/s41598-025-94148-1","article-title":"Preclinical assessment of a ganglioside-targeted therapy for Parkinson\u2019s disease with the first-in-class adaptive peptide AmyP53","volume":"15","author":"Fantini","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108797","article-title":"Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: target the target, not the arrow","volume":"267","author":"Fantini","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2026.116041_bb0170","article-title":"ATP13A2 declines zinc-induced accumulation of \u03b1-Synuclein in a Parkinson\u2019s disease model","volume":"23","author":"Gao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-023-02585-x","article-title":"Galectin-3 shapes toxic alpha-synuclein strains in Parkinson\u2019s disease","volume":"146","author":"Garc\u00eda-Revilla","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0180","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12640-020-00238-5","article-title":"Butyrate protects against Salsolinol-induced toxicity in SH-SY5Y cells: implication for Parkinson\u2019s disease","volume":"38","author":"Getachew","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113716","article-title":"Crosstalk between SIRT1\/Nrf2 signaling and NLRP3 inflammasome\/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson\u2019s disease","volume":"145","author":"Ghaith","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0190","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1007\/s12035-023-03530-5","article-title":"Metformin and trehalose-modulated autophagy exerts a neurotherapeutic effect on Parkinson\u2019s disease","volume":"60","author":"Gopar-Cuevas","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102308","article-title":"Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson\u2019s disease via promoting PLIN4 degradation","volume":"52","author":"Han","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0200","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1021\/acs.molpharmaceut.4c00879","article-title":"Investigating the mechanisms of antibody binding to alpha-Synuclein for the treatment of Parkinson\u2019s disease","volume":"21","author":"Harrison","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.expneurol.2026.116041_bb0205","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","article-title":"Treatment with Trehalose prevents behavioral and neurochemical deficits produced in an AAV \u03b1-synuclein rat model of Parkinson\u2019s disease","volume":"53","author":"He","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.761773","article-title":"TFE3-mediated autophagy is involved in dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"9","author":"He","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4665530","article-title":"The potential role of voltage-dependent anion channel in the treatment of Parkinson\u2019s disease","volume":"2022","author":"He","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.116041_bb0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","article-title":"miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"Hu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0230","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.21037\/apm-22-1356","article-title":"The safety and effectiveness of \u03b1-synuclein immunotherapy vs. placebo for the treatment of Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Hu","year":"2022","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0235","article-title":"Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Parkinson\u2019s disease","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0240","article-title":"Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102214","article-title":"The mechanism of cuproptosis in Parkinson\u2019s disease","volume":"95","author":"Huang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0250","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 Inflammasome activation and Pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115093","article-title":"Suppression of cGAS\/STING pathway-triggered necroptosis in the hippocampus relates H(2)S to attenuate cognitive dysfunction of Parkinson\u2019s disease","volume":"385","author":"Huang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102872","article-title":"Understanding the influence of TLR-mediated immune system on necroptosis-induced neurodegeneration in Parkinson\u2019s disease","volume":"112","author":"Jadhav","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.stem.2025.01.006","article-title":"Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease","volume":"32","author":"Jeon","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2026.116041_bb0270","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1038\/s41467-023-43870-3","article-title":"Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson\u2019s disease","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0275","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/med.21939","article-title":"Novel druggable mechanism of Parkinson\u2019s disease: potential therapeutics and underlying pathogenesis based on ferroptosis","volume":"43","author":"Jiang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0280","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5577541","article-title":"Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with Parkinson\u2019s disease","volume":"2021","author":"Jim\u00e9nez-Delgado","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0285","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2026.116041_bb0290","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acschemneuro.2c00659","article-title":"Exploring the epigenetic regulated modulation of fibroblast growth factor 21 involvement in high-fat diet associated Parkinson\u2019s disease in rats","volume":"14","author":"Kakoty","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications","volume":"71","author":"Kalyanaraman","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0300","article-title":"Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson\u2019s disease: an observational and case-control study","volume":"1","author":"Kannarkat","year":"2015","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008868","article-title":"Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson\u2019s disease through mitochondrial dysfunction","volume":"16","author":"Kao","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2026.116041_bb0310","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116041_bb0315","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-024-01498-2","article-title":"Tribuli Fructus alleviates 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson\u2019s disease by suppressing neuroinflammation via JNK signaling","volume":"40","author":"Kim","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0320","doi-asserted-by":"crossref","unstructured":"Koller, W.C., Rueda, M.G., 1998. Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology 50, S11-14; discussion S44-18.","DOI":"10.1212\/WNL.50.6_Suppl_6.S11"},{"key":"10.1016\/j.expneurol.2026.116041_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080918","article-title":"Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease","volume":"9","author":"Kung","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.expneurol.2026.116041_bb0330","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1038\/s41598-023-35975-y","article-title":"Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and \u03b1-synuclein oligomerization in a subacute MPTP mouse model of Parkinson\u2019s disease","volume":"13","author":"Leem","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109586","article-title":"Creatine supplementation with exercise reduces \u03b1-synuclein oligomerization and necroptosis in Parkinson\u2019s disease mouse model","volume":"126","author":"Leem","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.expneurol.2026.116041_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105605","article-title":"Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease","volume":"163","author":"Li","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0345","first-page":"1322","article-title":"Botulinum neurotoxin a ameliorates depressive-like behavior in a reserpine-induced Parkinson\u2019s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.expneurol.2026.116041_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115167","article-title":"Targeting the NLRP3 inflammasome in Parkinson\u2019s disease: from molecular mechanism to therapeutic strategy","volume":"386","author":"Liang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JPD-230376","article-title":"Parkinson\u2019s disease is predominantly a genetic disease","volume":"14","author":"Lim","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP(+)\/MPTP-induced dopaminergic neuron death in Parkinson\u2019s disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0365","article-title":"Tianma Gouteng Yin, a traditional Chinese medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson\u2019s disease","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0370","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","article-title":"Balancing apoptosis and autophagy for Parkinson\u2019s disease therapy: targeting BCL-2","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0375","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4103\/1673-5374.371381","article-title":"Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson\u2019s disease","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-023-02755-4","article-title":"NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson\u2019s disease models","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.116041_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi8716","article-title":"Anionic nanoplastic contaminants promote Parkinson\u2019s disease-associated \u03b1-synuclein aggregation","volume":"9","author":"Liu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2026.116041_bb0390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-15-4272-5_2","article-title":"Autophagy and Parkinson\u2019s disease","volume":"1207","author":"Lu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0395","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u0391-Synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115266","article-title":"Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease via the prosaposin-GPR37-IL-6 axis","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2026.116041_bb0415","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-024-49016-3","article-title":"Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0420","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1038\/s41467-023-43224-z","article-title":"Brain-to-gut trafficking of alpha-synuclein by CD11c(+) cells in a mouse model of Parkinson\u2019s disease","volume":"14","author":"McFleder","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0425","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u0391-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.expneurol.2026.116041_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1092","article-title":"The yeast prion protein Sup35 initiates \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease","volume":"9","author":"Meng","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2026.116041_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314997","article-title":"Neuroinflammation and autophagy in Parkinson\u2019s disease-novel perspectives","volume":"23","author":"Minchev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030222","article-title":"Microbiome, Parkinson\u2019s disease and molecular mimicry","volume":"8","author":"Miraglia","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.116041_bb0445","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies","volume":"48","author":"Moradi Vastegani","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0450","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2026.116041_bb0455","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0460","article-title":"N-acetylcysteine nanocarriers protect against oxidative stress in a cellular model of Parkinson\u2019s disease","volume":"9","author":"Mursaleen","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.expneurol.2026.116041_bb0465","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-023-02673-y","article-title":"Catecholamines and Parkinson\u2019s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview","volume":"131","author":"Nagatsu","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.expneurol.2026.116041_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147609","article-title":"The link between the gut microbiota and Parkinson\u2019s disease: a systematic mechanism review with focus on \u03b1-synuclein transport","volume":"1769","author":"Nielsen","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0475","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau0713","article-title":"Gene therapy reduces Parkinson\u2019s disease symptoms by reorganizing functional brain connectivity","volume":"10","author":"Niethammer","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0480","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/mds.27993","article-title":"Aromatic L-amino acid decarboxylase gene therapy enhances levodopa response in Parkinson\u2019s disease","volume":"35","author":"Nutt","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.116041_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112715","article-title":"Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson\u2019s disease","volume":"139","author":"Ovlyakulov","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0490","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson's disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.116041_bb0495","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/aps.2013.57","article-title":"6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson\u2019s disease models via anti-neuroinflammation","volume":"34","author":"Park","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.expneurol.2026.116041_bb0500","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/hmg\/ddt623","article-title":"Parkinson\u2019s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction","volume":"23","author":"Park","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2026.116041_bb0505","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.116041_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2024.111942","article-title":"Understanding the (epi)genetic dysregulation in Parkinson\u2019s disease through an integrative brain competitive endogenous RNA network","volume":"219","author":"Piergiorge","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010191","article-title":"The consequences of GBA deficiency in the autophagy-lysosome system in Parkinson\u2019s disease associated with GBA","volume":"12","author":"Pradas","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.116041_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135493","article-title":"Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP\/MPP(+)-induced Parkinson\u2019s disease","volume":"741","author":"Qi","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.116041_bb0525","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153234","article-title":"Lysosomal K(+) channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson\u2019s disease","volume":"23","author":"Qu","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0530","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00018-022-04389-w","article-title":"Restricting \u03b1-synuclein transport into mitochondria by inhibition of \u03b1-synuclein-VDAC complexation as a potential therapeutic target for Parkinson\u2019s disease treatment","volume":"79","author":"Rajendran","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094956","article-title":"Epigenetic regulation of Neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Rasheed","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0540","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ejn.16136","article-title":"Dopaminergic neuronal death via necroptosis in Parkinson\u2019s disease: a review of the literature","volume":"59","author":"Regoni","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03241-9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates \u03b1-synuclein","volume":"9","author":"Ryan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0550","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.116041_bb0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.116041_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176641","article-title":"Epigenetic modifications in Parkinson\u2019s disease: a critical review","volume":"975","author":"Sharma","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122656","article-title":"Cell therapy for Parkinson\u2019s disease","volume":"15","author":"Shastry","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.expneurol.2026.116041_bb0570","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm4560","article-title":"Ca(v)1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons","volume":"8","author":"Shin","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2026.116041_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094724","article-title":"Synaptic zinc: an emerging player in Parkinson\u2019s disease","volume":"22","author":"Sikora","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0580","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2025.1687","article-title":"Ambroxol as a treatment for Parkinson disease dementia: a randomized clinical trial","volume":"82","author":"Silveira","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0585","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuro.2021.03.009","article-title":"IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease","volume":"84","author":"Sodhi","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2026.116041_bb0590","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/ene.14918","article-title":"P2X7 receptor\/NLRP3 inflammasome complex and \u03b1-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-na\u00efve Parkinson\u2019s disease","volume":"28","author":"Solini","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0595","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u0391-Synuclein in Parkinson\u2019s disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134087","article-title":"PGC-1\u03b1 promoter methylation in Parkinson\u2019s disease","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.116041_bb0605","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70018","article-title":"Dopamine-conjugated extracellular vesicles induce autophagy in Parkinson\u2019s disease","volume":"13","author":"Sul","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.expneurol.2026.116041_bb0610","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.878239","article-title":"Update to the treatment of Parkinson\u2019s disease based on the gut-brain axis mechanism","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0620","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.ymthe.2025.03.030","article-title":"Recent developments in gene therapy for Parkinson\u2019s disease","volume":"33","author":"Szunyogh","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2026.116041_bb0625","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2013.159","article-title":"Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson\u2019s disease","volume":"21","author":"Tang","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2026.116041_bb0630","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.3233\/JPD-223245","article-title":"Neuroinflammation and immune changes in prodromal Parkinson\u2019s disease and other synucleinopathies","volume":"12","author":"Terkelsen","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0635","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 inhibits Ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson\u2019s disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2026.116041_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.11.017","article-title":"Gut microbiome in Parkinson\u2019s disease: new insights from meta-analysis","volume":"94","author":"Toh","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2026.116041_bb0645","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13522","article-title":"\u0391-Synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"20","author":"Tu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2026.116041_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0655","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112385","article-title":"Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson\u2019s disease via the activation of Nrf2\/keap1 pathway","volume":"199","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.expneurol.2026.116041_bb0665","article-title":"Chicoric acid prevents neuroinflammation and neurodegeneration in a mouse Parkinson\u2019s disease model: immune response and transcriptome profile of the spleen and colon","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0670","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0675","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-023-04484-x","article-title":"Cell-therapy for Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0680","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41401-022-01039-6","article-title":"Pharmacological characterization of the small molecule 03A10 as an inhibitor of \u03b1-synuclein aggregation for Parkinson\u2019s disease treatment","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.expneurol.2026.116041_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156146","article-title":"Lignans of Schisandra chinensis (Turcz.) Baill inhibits Parkinson's disease progression through mediated neuroinflammation-TRPV1 expression in microglia","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.expneurol.2026.116041_bb0690","first-page":"825","article-title":"Dual-pathway targeted therapy for Parkinson\u2019s disease: biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation","volume":"51","author":"Wang","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.expneurol.2026.116041_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103493","article-title":"Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells","volume":"105","author":"Wenzel","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0700","article-title":"Ferroptosis as a new mechanism in Parkinson\u2019s disease therapy using traditional Chinese medicine","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154250","article-title":"Artemisia leaf extract protects against neuron toxicity by TRPML1 activation and promoting autophagy\/mitophagy clearance in both in vitro and in vivo models of MPP+\/MPTP-induced Parkinson\u2019s disease","volume":"104","author":"Wu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.expneurol.2026.116041_bb0710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/atm-22-5756","article-title":"Machine learning screening for Parkinson's disease-related cuproptosis-related typing development and validation and exploration of personalized drugs for cuproptosis genes","volume":"11","author":"Wu","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0715","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156768","article-title":"Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson\u2019s disease model","volume":"132","author":"Xu","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2026.116041_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120079","article-title":"Proteomics based discovery of Salvia miltiorrhiza Bunge treating Parkinson\u2019s disease through the PINK1\/Parkin pathway","volume":"350","author":"Xu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10719-021-10012-0","article-title":"Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic \u03b1-synuclein oligomers in Parkinson\u2019s disease","volume":"39","author":"Yahi","year":"2022","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.expneurol.2026.116041_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102063","article-title":"Research progress in the molecular mechanism of ferroptosis in Parkinson\u2019s disease and regulation by natural plant products","volume":"91","author":"Yang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.116041_bb0735","article-title":"The potential of natural products to inhibit abnormal aggregation of \u03b1-Synuclein in the treatment of Parkinson\u2019s disease","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114972","article-title":"Astragaloside IV ameliorates Parkinson\u2019s disease by inhibiting TLR4\/NF-\u03baB-dependent neuroinflammation","volume":"160","author":"Yang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0745","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4103\/1673-5374.235075","article-title":"Zishenpingchan granules for the treatment of Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"13","author":"Ye","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2026.116041_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson\u2019s disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0755","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0760","article-title":"Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-Synuclein and enhance therapy of Parkinson\u2019s disease","volume":"34","author":"Yuan","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.expneurol.2026.116041_bb0765","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","article-title":"Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease","volume":"28","author":"Yuan","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0770","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","article-title":"Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments","volume":"50","author":"Zamanian","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.expneurol.2026.116041_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092045","article-title":"Calcium, bioenergetics, and Parkinson\u2019s disease","volume":"9","author":"Zampese","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.116041_bb0780","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.18632\/aging.103215","article-title":"Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.expneurol.2026.116041_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13071015","article-title":"Identification of Cuproptosis clusters and integrative analyses in Parkinson\u2019s disease","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0790","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41531-023-00453-9","article-title":"Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson's disease","volume":"9","author":"Zhang","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116041_bb0795","article-title":"How toll-like receptors influence Parkinson\u2019s disease in the microbiome-gut-brain axis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0800","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12035-023-03565-8","article-title":"Identification of key genes and immunological features associated with copper metabolism in Parkinson\u2019s disease by bioinformatics analysis","volume":"61","author":"Zhang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111001","article-title":"Study on the mechanism of gut microbiota in the pathogenetic interaction between depression and Parkinson \u2019s disease","volume":"215","author":"Zhang","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2026.116041_bb0810","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43556-024-00213-y","article-title":"Identification of nitric oxide-mediated necroptosis as the predominant death route in Parkinson's disease","volume":"5","author":"Zhang","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.expneurol.2026.116041_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129564","article-title":"The potential of Rhein\u2019s aromatic amines for Parkinson\u2019s disease prevention and treatment: \u03b1-Synuclein aggregation inhibition and disaggregation of preformed fibers","volume":"97","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2026.116041_bb0820","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","article-title":"Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death","volume":"119","author":"Zhang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2026.116041_bb0825","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.joim.2024.07.002","article-title":"Efficacy and safety of Tianqi Pingchan granule, a compound Chinese herbal medicine, for levodopa-induced dyskinesia in Parkinson\u2019s disease: a randomized double-blind placebo-controlled trial","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.expneurol.2026.116041_bb0830","article-title":"The GLP-1 receptor agonist liraglutide inhibits necroptosis and neuroinflammation in a mouse model of Parkinson\u2019s disease with diabetes co-morbidity","volume":"19","author":"Zhang","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0835","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.expneurol.2026.116041_bb0840","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2018.02.011","article-title":"Novel DNA aptamers for Parkinson\u2019s disease treatment inhibit \u03b1-Synuclein aggregation and facilitate its degradation","volume":"11","author":"Zheng","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.expneurol.2026.116041_bb0845","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1073858420943180","article-title":"\u0391-Synuclein in Parkinson\u2019s disease: does a prion-like mechanism of propagation from periphery to the brain play a role?","volume":"27","author":"Zheng","year":"2021","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2026.116041_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113608","article-title":"Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson\u2019s disease induced by rotenone","volume":"143","author":"Zheng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2026.116041_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111212","article-title":"A derivative of honokiol HM568 has an anti-neuroinflammatory effect in Parkinson\u2019s disease","volume":"403","author":"Zhong","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.expneurol.2026.116041_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313042","article-title":"Targeting Ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.116041_bb0865","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-023-02989-2","article-title":"Targeting CB2R in astrocytes for Parkinson\u2019s disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflammation"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:48Z","timestamp":1792728288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626004085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":173,"alternative-id":["S0014488626004085"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116041","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of multidimensional molecular mechanisms in Parkinson's disease and precise therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116041"}}